{"id":12006,"date":"2025-04-18T11:16:46","date_gmt":"2025-04-18T09:16:46","guid":{"rendered":"https:\/\/valintermed.com\/?p=12006"},"modified":"2025-04-18T11:16:46","modified_gmt":"2025-04-18T09:16:46","slug":"makulyarnaya-distrofiya-rogovitsy-tip-1","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/macular-degeneration-type-1\/","title":{"rendered":"Macular corneal dystrophy type 1"},"content":{"rendered":"
<\/div>\n

Macular corneal dystrophy type 1 (MCD1) is a rare hereditary disease caused by degeneration of the corneal stroma, which can lead to impaired corneal transparency and decreased vision. This pathology, as a rule, has a dominant type of inheritance and is associated with changes in the collagen structure. MCD1 often manifests itself in childhood or adolescence, which makes diagnosis and initiation of treatment especially relevant for preventing disease progression and improving the quality of life of patients. The cornea, being a key element of light refraction in the eyeball, is of strategic importance for visual acuity, and any disease of it necessarily affects visual function. It is important to note that macular corneal dystrophy can be combined with other ophthalmological disorders, which requires an integrated approach to diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n